Blockade of programmed cell death protein 1 (PD-1) in Sézary syndrome reduces Th2 phenotype of non-tumoral T lymphocytes but may enhance tumor proliferation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Blockade of programmed cell death protein 1 (PD-1) in Sézary syndrome reduces Th2 phenotype of non-tumoral T lymphocytes but may enhance tumor proliferation

Published:2020-01-01 Issue:1 Volume:9 Page:
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Saulite Ieva¹²,Ignatova Desislava¹,Chang Yun-Tsan¹,Fassnacht Christina¹,Dimitriou Florentia¹,Varypataki Eleni¹,Anzengruber Florian¹,Nägeli Mirjam¹,Cozzio Antonio²,Dummer Reinhard¹,Scarisbrick Julia³,Pascolo Steve¹,Hoetzenecker Wolfram⁴,Bobrowicz Malgorzata⁵,Guenova Emmanuella¹⁶

Affiliation:

1. Department of Dermatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland

2. Department of Dermatology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland

3. Department of Dermatology, University Hospitals Birmingham, Birmingham, UK

4. Department of Dermatology, Kepler University Hospital, Linz, Austria

5. Department of Immunology, Medical University of Warsaw, Warsaw, Poland

6. Department of Dermatology, Lausanne University Hospital CHUV, University of Lausanne, Lausanne, Switzerland

Funder

the European Commission Horizon 2020 Programme

The Polish National Science Centre and an EMBO

European Academy of Dermatology and Venereology

the Swiss Cancer Research Foundation

Promedica Stiftung

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung

Universität Zürich

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2020.1738797

Reference86 articles.

1. The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas

2. Early clinical manifestations of Sézary syndrome: A multicenter retrospective cohort study

3. Characteristics associated with significantly worse quality of life in mycosis fungoides/Sézary syndrome from the Prospective Cutaneous Lymphoma International Prognostic Index ( PROCLIPI ) study

4. Sézary syndrome and mycosis fungoides arise from distinct T-cell subsets: a biologic rationale for their distinct clinical behaviors

5. Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and Sézary Syndrome: Effect of Specific Prognostic Markers on Survival and Development of a Prognostic Model

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of Sézary cell marker expression and cell death behaviour upon in vitro treatment by flow cytometry in Sézary syndrome patients;Experimental Dermatology;2024-09

2. Evaluating trophinin associated protein as a biomarker of prognosis and therapy response in renal cell carcinoma;BMC Cancer;2024-08-17

3. Unleashed monocytic engagement in Sézary syndrome during the combination of anti-CCR4 antibody with type I interferon;Blood Advances;2024-05-17

4. The Role of Cytokines in Cutaneous T Cell Lymphoma: A Focus on the State of the Art and Possible Therapeutic Targets;Cells;2024-03-28

5. Role of Antigenic Stimulation in Cutaneous T-Cell Lymphomas;Journal of Investigative Dermatology;2023-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3